AXA announced results and pricing of its separate invitations to eligible holders of its outstanding £350,000,000 Fixed to Floating Rate Undated Deeply Subordinated Notes the "Series 23 Notes" and £723,925,000 Undated Deeply Subordinated Resettable Notes the "Series 37 Notes" and, together with the Series 23 Notes, the "Notes" to tender any and all of such Notes for purchase by the Offeror for cash subject to the satisfaction (or waiver by the Offeror) of the conditions set out in, and all as further described in, the tender offer memorandum dated 26 February 2024 the "Tender Offer Memorandum" . The Offers were announced on 26 February 2024 and were made on the terms and subject to the conditions contained in the Tender Offer Memorandum. Capitalized terms used in this announcement but not otherwise defined shall have the meanings given to them in the Tender Offer Memorandum.

The Expiration Deadline for the Offers was 5.00 p.m. (Central European time) on 4 March 2024. As at the Expiration Deadline, £333,981,000 in aggregate nominal amount of the Series 23 Notes and £662,238,000 in aggregate nominal amount of the Series 37 Notes were validly tendered for purchase pursuant to the Offers. The Offeror hereby announces that it has decided to accept for purchase all Notes validly tendered pursuant to the Offers.